Hospira Recalls Quelicin Injection Due to Labeling Errors
Hospira Inc. recalls Quelicin (Succinylcholine Chloride) Injection vials because the lot number or expiration date may be faded or missing from the label.
Use caution until it’s fixed
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.
Contact the company
What happened, in plain English
Hospira Inc. is recalling Quelicin (Succinylcholine Chloride) Injection, USP 200 mg (20 mg/mL), 10 mL multiple-dose vials packaged in cartons of 25 units. The issue involves the primary label on the glass vial, where the lot number and/or expiration date may be faded or missing. This affects product NDC 0409-6629-02 with Lot 52-045-EV and an expiration date of 07/1/2016. Read more at govinfonow.com/recall/43110-hospira-recalls-quelicin-injection-due-to-labeling-errors.
Source Summary by GovInfoNow · govinfonow.com/recall/43110-hospira-recalls-quelicin-injection-due-to-labeling-errors · Updated October 11, 2026 · FDA enforcement record: FDA #D-0836-2016
Cite this page
“Hospira Recalls Quelicin Injection Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43110-hospira-recalls-quelicin-injection-due-to-labeling-errors. Based on FDA recall #D-0836-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0836-2016%22&limit=1).
Why it’s dangerous
The missing or faded labeling prevents healthcare professionals from verifying the lot number and expiration date of the drug. This creates a risk of administering expired medication or being unable to track the specific batch in case of future safety issues or contamination events.
Who’s affected
Healthcare providers and facilities that have received or administered this specific lot of Quelicin injection vials are affected. Patients who may have received medication from these vials are also at risk due to the inability to verify product identity and expiration.
How to tell if you have this one
Check for Quelicin (Succinylcholine Chloride) Injection, USP 200 mg (20 mg/mL), 10 mL multiple-dose vials. Look for NDC 0409-6629-02 and Lot 52-045-EV with an expiration date of 07/1/2016. Inspect the primary label on the glass vial to see if the lot number or expiration date is faded or missing.
- Brand
Hospira- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 57 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0836-2016 (March 15, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0836-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.